Ali Turhan

Ali Turhan

Company: iPSirius

Job title: Chief Medical Officer

Seminars:

Roundtable Discussion: Identifying Factors Contributing to iPSC Genomic Instability 2:00 pm

Identifying factors that contribute to genomic instability in iPSCs and their impact on therapeutic outcomes Developing novel techniques to identify genomic instability at the level of iPSCs and derived cells Exploring strategies to mitigate genomic instability, including optimized reprogramming techniques and targeted genetic modificationsRead more

day: Day One Track A Afternoon

Advancing Cancer Modeling with iPSCs: Current Approaches & Opportunities 3:00 pm

Modeling hereditary cancers using iPSC-derived cancer organoids Understanding novel signaling pathways in cancer progression Uncovering novel targets for drug and future cell therapiesRead more

day: Day Two Afternoon

A Hanson Wade Group Company

© Copyright 2025 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.